Superman 75 (Cialis 25 – Viagra 50)

Superman 75 – Product Overview

Superman 75 combines two well-known PDE5 inhibitors — Sildenafil Citrate (50mg) and Tadalafil Citrate (25mg) — into a single research-ready formulation. Each bottle provides 50 tablets at a total potency of 75mg per tablet. This dual-action composition is frequently examined in studies involving vascular physiology, erectile-function mechanisms, and nitric-oxide–mediated smooth-muscle responses.

Scientific Background

Sildenafil and Tadalafil both inhibit phosphodiesterase type-5 (PDE5), an enzyme responsible for breaking down cGMP — a key regulator of vasodilation in erectile tissue. Sildenafil is known for its relatively fast onset, while Tadalafil has a much longer duration of action. The combination allows researchers to examine both immediate and extended PDE5-inhibitory effects in a single compound.

Key Research-Based Characteristics

• Dual PDE5 Inhibition: Provides two pharmacokinetic profiles for studying nitric-oxide/cGMP signaling dynamics.
• Enhanced Vasodilation: Investigated for effects on smooth-muscle relaxation and blood-flow regulation.
• Short- and Long-Acting Synergy: Sildenafil offers rapid engagement; Tadalafil contributes prolonged PDE5 inhibition.
• Endothelial Response Research: Supports studies involving endothelial nitric-oxide pathways.
• Non-Hormonal Mechanism: Acts enzymatically without influencing androgen or estrogen signaling.

Product Composition

• Quantity: 50 tablets
• Total Strength: 75mg per tablet
• Active Breakdown:
  • 50mg Sildenafil Citrate
  • 25mg Tadalafil Citrate
• Compound Type: Phosphodiesterase type-5 inhibitors (PDE5i)
• Form: Oral tablet

Research Applications

• Erectile-function mechanism studies involving cGMP and nitric oxide
• Vascular and circulatory research exploring smooth-muscle relaxation
• Comparative inhibitor profiling of short- vs. long-acting PDE5 inhibitors
• Endothelial signaling investigations focused on vasodilation performance

Why Choose Superman 75?

Superman 75 offers the combined benefits of two of the most studied PDE5 inhibitors, delivering both rapid and extended activity within a single, research-grade formulation. With 50 tablets at a precise 75mg total potency per tablet, this blend provides a versatile tool for studies involving vascular function, erectile physiology, and nitric-oxide–mediated signaling.

Enhance your vascular and sexual-function research with Superman 75 — a dual-action PDE5-inhibitor formulation designed for comprehensive nitric-oxide pathway exploration.